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Inhibition of Arginase Activity Ameliorates
L-ArginineYInduced Acute Pancreatitis in Rats
Gyo¨rgy Biczo´, MSc,* Pe´ter Hegyi, MD, PhD,* Sa´ndor Berczi, MD,Þ Sa´ndor Do´sa, MD,Þ
Zsuzsanna Hracsko´, MSc,þ Ilona S. Varga, PhD,þ Be´la Iva´nyi, MD, PhD, DSc,Þ Vikto´ria Venglovecz, PhD,§
Tibor Wittmann, MD, PhD,* Tama´s Taka´cs, MD, PhD, DSc,* and Zolta´n Rakonczay Jr, MD, PhD*
Objectives: Intraperitoneal (IP) injection of 3.5 g/kg L-arginine (known
to induce acute pancreatitis) in rats will result in much greater increases
in serum ornithine versus citrulline concentration (Crit Care Med. 2008;
36:2117Y2127). These data indicate a major role of arginase in the cata-
bolism of L-arginine. Therefore, we tested the effects of the irreversible
arginase inhibitor (+)-S-2-amino-6-iodoacetamidohexanoic acid (AIHA)
on L-arginineYinduced acute pancreatitis.
Methods: The inhibitory effect of AIHA on arginase activity was
tested on rat liver homogenate and puriﬁed bovine arginase. Male Wistar
rats were administered 15 mg/kg AIHA or its vehicle IP 1 hour before
the injection of physiological saline or 3.5 g/kg L-arginine IP. Lab-
oratory and histological parameters of pancreatitis were determined
24 hours after the last injection.
Results: Sixty micromolars of AIHA (equimolar to an in vivo dose
of 15 mg/kg) signiﬁcantly inhibited arginase activity by about 25%.
Pretreatment with AIHA signiﬁcantly ameliorated pancreatic damage
caused by L-arginine administration. It decreased pancreatic weight/body
weight ratio, pancreatic glutathione peroxidase and myeloperoxidase
activities, and histological damage. Administration of AIHA in itself
signiﬁcantly increased levels of pancreatic heat shock proteins.
Conclusions: Pretreatment with AIHA reduces the severity of L-
arginineYinduced pancreatitis most likely by inhibiting arginase activity.
Key Words: arginase, L-arginine,
(+)-S-2-amino-6-iodoacetamidohexanoic acid, acute pancreatitis
(Pancreas 2010;00: 00Y00)
L arge doses (2.5Y5 g/kg) of intraperitoneally (IP) injectedL-arginine are known to induce acute necrotizing pancrea-
titis in rats and mice.1Y4 The pathomechanism of L-arginine
pancreatitis is unknown, especially concerning the early events
leading to the disease.
Two key enzymes that are involved in the metabolism
of L-arginine are nitric oxide synthase (NOS) and arginase
(F1 Fig. 1).5 Nitric oxide synthase has 3 isoforms: the constitutive
endothelial (eNOS) and neuronal (nNOS) and an inducible form
(iNOS). They catalyze the conversion of L-arginine to nitric oxide
and L-citrulline. Arginase, which has 2 isoforms (types I and II),
hydrolyzes L-arginine to L-ornithine and urea. These 2 arginase
isoforms are encoded by 2 different genes and differ in molecular
properties, tissue distribution, subcellular location, and regulation
of expression. Arginase I is localized in the cytosol and is highly
expressed in the liver and to a much less extent in a few other
tissues. Arginase II is a mitochondrial enzyme, which is widely
distributed in extrahepatic tissues.
In arginine-induced pancreatitis, pancreatic constitutive NOS
activity was depleted at 6 hours then gradually increased to sig-
niﬁcantly higher level than the control at 24 hours.6 The activity
of pancreatic iNOS was signiﬁcantly increased at 24 hours after
L-arginine injection.
Most of the IP injected L-arginine is converted to L-
ornithine rather than L-citrulline,7,8 therefore indicating a major
role of arginase in the catabolism of this basic amino acid.
Furthermore, we have recently shown that administration of L-
ornithine induces a more severe pancreatitis compared with L-
arginine.7 Therefore, we speculated that L-arginine produces a
toxic effect on the pancreas, at least in part, via L-ornithine. The
aim of this study was to test the effects of the irreversible ar-
ginase inhibitor (+)-S-2-amino-6-iodoacetamidohexanoic acid
(AIHA) on L-arginineYinduced acute pancreatitis.
MATERIALS AND METHODS
Materials
(+)-S-2-amino-6-iodoacetamidohexanoic acid was pur-
chased from Alexis Biochemicals AQ1. All other chemicals were
obtained from Sigma-Aldrich, unless indicated otherwise.
Animals
Male Wistar rats weighing 220 to 250 g were used. The
animals were kept at a constant room temperature of 23-C with
a 12-hour light-dark cycle and were allowed free access to
water and standard laboratory chow (Biofarm, Zagyvasza´nto´,
Hungary). In each experimental group, 5 to 8 rats were used. The
experiments performed in this study were approved by the
Animal Care Committee of the University.
Experimental Protocol
Rats were pretreated with 15 mg/kg AIHA (dissolved in
6 M HCl and pH set to 7.4 with NaOH in phosphate-buffered
saline) or its vehicle IP 1 hour before injection with physio-
logical saline or 3.5 g/kg L-arginineYHCl (350 mg/mL, pH: 7.4)
IP. Rats were killed by exsanguination through the abdomi-
nal aorta after anesthetization with 44 mg/kg pentobarbital IP
24 hours after the L-arginine or physiological saline injection.
The pancreas was quickly removed, cleaned from fat and lymph
nodes, weighed, and frozen in liquid nitrogen and stored at
j80-C until use. Furthermore, liver, kidney, and lung tissue
were frozen from control animals for determination of arginase
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activity. All blood samples were centrifuged at 2500 g for
20 minutes, and the serum was stored at j25-C.
Pancreatic Weight/Body Weight Ratio
The pancreatic weight/body weight (PW/BW) ratio was
used to evaluate the degree of pancreatic edema.
Serum and Pancreatic Amylase Activity
The serum and pancreatic activities of amylase were de-
termined by a colorimetric kinetic method (Dialab, Vienna,
Austria).
Pancreatic Trypsin Activity
Pancreas samples were pulverized under liquid N2 using
a mortar and pestle. Pulverized tissue was suspended in ice-
cold MOPS (3-[N-morpholino]propanesulfonic acid) buffer
(5 mM MOPS, pH 6.5, 250 mM sucrose, 1 mM MgSO4). The
resulting homogenate was centrifuged (50 g for 5 minutes), and
the supernatant was used for the enzyme assay. Trypsin activity
was measured in Tris buffer (50 mM Tris, pH 8.0, 150 mM
NaCl, 1 mM CaCl2) by using the colorimetric substrate N-
CBZ-Gly-Pro-Arg-p-nitroanilide (0.1 mM ﬁnal concentration;
Bachem GmbH, Weil am Rhein, Germany). Three-minute time
courses of p-nitroaniline release were followed at 405 nm at
room temperature with a Hitachi U-2900 spectrophotometerAQ2 .
Trypsin activity in the homogenate was estimated using a stan-
dard curve for puriﬁed bovine trypsin.
Arginase Activity
Parts of the liver, pancreas, kidney, and lung were homo-
genized in 9-fold excess (wt/vol) of ice-cold buffer containing
50 mM Tris-HCl (pH 7.5) supplemented with 1 mM phenyl
methyl sulfonyl ﬂuoride, 4 mM benzamidine, and 100 U/mL
aprotinin using an Ultra-Turrax homogenizer AQ3for 2  30 seconds.
The homogenates were then centrifuged at 25,000 g for 30 min-
utes (at 4-C), and the heat-activated (60-C, 20 minutes) superna-
tants (their protein concentrations were measured by the method
of Bradford14) were used for determination of arginase activity.
Arginase activity was measured by exogenously added L-arginine
using a colorimetric method, based on the determination of re-
leased urea.9 Brieﬂy, 20 mM L-arginineYHCl substrate (pH set
to 9.7), 0.2 mM MnCl2, and the sample were mixed in 250 KL
and incubated at 37-C for 5 to 15 minutes. The reaction was
stopped by adding 250 KL 1 N HClO4 and centrifuged, and
140 KL supernatant was used for urea determination by adding
1.36 mL diacetylmonoximethiosemicarbazide reagent after cen-
trifugation; an aliquot was tested for released urea according
to Coulombe and Favreau.10 After heating at 100-C (20 minutes)
and cooling, optical densities were read at 535 nm using urea
standards.
The inhibitory effect of 0 to 120 KM AIHA on arginase
activity was tested on rat liver homogenate and puriﬁed bovine
liver arginase (Serva AQ4). Considering that the total water content
of the rat is about 80%, 60 KM AIHA is equimolar to an in vivo
dose of 15 mg/kg.
Pancreatic Myeloperoxidase Activity
Pancreatic myeloperoxidase (MPO) activity, as a marker
of tissue leukocyte inﬁltration, was assessed using the method
of Kuebler et al.11
Pancreatic Nonprotein Sulfhydryl Group Content
and the Activities of Glutathione Peroxidase
and Superoxide Dismutase
To determine nonprotein sulfhydryl group (NSG) content and
activities of glutathione peroxidase (GSH-Px), MnY and Cu/ZnY
superoxide dismutase (SOD), a part of the pancreas was homo-
genized, the homogenates centrifuged at 3000 g for 10 minutes,
and the supernatants were used for measurements as described
previously.12
Expression of Pancreatic Heat Shock Proteins
27 and 72
Heat shock proteins (HSPs) are stress-inducible chaperones.
Western blot analysis of pancreatic HSP27 and HSP72 expression
was performed from the cytosolic fraction of the pancreas homo-
genate. Pancreatic cytosolic fractions were prepared as described
previously.13 The protein concentration of the homogenate was
determined by the method of Bradford.14 Forty micrograms of
protein was loaded per lane. Samples were electrophoresed on a
10% sodium dodecyl sulfateYpolyacrylamide gel according to
the method of Laemmli.15 The proteins on the gels were either
stained with Coomassie brilliant blue (to demonstrate equal
loading of proteins for Western blot analysis) or transferred to a
nitrocellulose membrane for 1 hour at 100 V. Equal transfer of
proteins was veriﬁed by ponceau S staining. Membranes were
blocked in 5% nonfat dry milk (Bio-Rad AQ5) for 1 hour and incu-
bated with rabbit anti-HSP72 (1:10,000 dilution, characterized
previously by Kurucz et al,16) or goat anti-HSP27 (1:500 dilution;
Santa Cruz Biotechnology, Santa Cruz, Calif ) antibody for an
additional 1 or 3 hours (respectively) at room temperature. The
FIGURE 1. Key enzymes involved in the metabolism of L-arginine.
Nitric oxide synthase catalyzes the conversion of L-arginine to
nitric oxide and L-citrulline. Arginase hydrolyzes L-arginine to
L-ornithine and urea.
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immunoreactive protein was visualized by enhanced chemilumi-
nescence using horseradish peroxidaseYcoupled antiYrabbit or
antiYgoat immunoglobulin (Dako, Glostrup, Denmark) at
1:10,000 dilution.
Histological Examination
A portion of the pancreas was ﬁxed in 6% neutral for-
maldehyde solution and subsequently embedded in parafﬁn.
Sections were cut at 4-Km thickness and stained with hematoxy-
lin and eosin. The slides were coded and read by 2 independent
observers whowere blind to the experimental protocol. Pancreatic
tissue injury was evaluated as described previously.7 Brieﬂy,
semiquantitative grading of interstitial edema (0Y3), vascular con-
gestion (0Y1), leukocyte adhesion (0Y3) and inﬁltration (0Y4),
and apoptosis (0Y3) and necrosis (0Y4) of acinar cells was deter-
mined in each animal.
Statistical Analysis
Results are expressed as means T SEM. Experiments were
evaluated by using the analysis of variance followed by Dunnett
multiple-comparisons post hoc test. Values of P G 0.05 were
considered as signiﬁcant.
RESULTS
Arginase Activity in the Liver, Pancreas, Lung,
and Kidney
Arginase activity was by far the highest in the liver ( F2Fig. 2).
Nevertheless, we could also detect arginase activity in the pan-
creas, lung, and kidney.
Effect of AIHA on Arginase Activity
(+)-S-2-amino-6-iodoacetamidohexanoic acid dose-
dependently inhibited liver arginase activity of rat liver ho-
mogenate and puriﬁed bovine arginase in vitro ( F3Fig. 3). Sixty
micromolars of AIHA (equimolar to an in vivo dose of 15 mg/kg)
signiﬁcantly inhibited liver arginase activity by about 25%.
PW/BW Ratio, Serum and Pancreatic Amylase
Activity, and Pancreatic Trypsin Activity
Pancreatic weight/body weight ratio was signiﬁcantly in-
creased in response to administration of L-arginine ( F4Fig. 4A).
Pretreatment with AIHA signiﬁcantly ameliorated this increase
of PW/BW ratio. Serum amylase activity was not signiﬁcantly
altered in any of the groups (Fig. 4B). Pancreatic contents of
amylase were signiﬁcantly decreased in the L-arginineYtreated
groups (Fig. 4C). Pretreatment with AIHA did not inﬂuence pan-
creatic amylase activity in rats injected with L-arginine. Pan-
creatic trypsin activity was signiﬁcantly increased by L-arginine
administration (Fig. 4D). Pretreatment with AIHA signiﬁcantly
ameliorated this increased pancreatic trypsin activity.
Pancreatic MPO Activity
Pancreatic MPO activity was signiﬁcantly increased at
24 hours after L-arginine injection (Fig. 4E). Pretreatment with
AIHA signiﬁcantly decreased MPO activity in the L-arginineY
induced pancreatitis group.
Pancreatic Nonprotein Sulfhydryl Group Content
and the Activities of GSH-Px and SOD
Pancreatic NSG content and GSH-Px activity were signiﬁ-
cantly increased 24 hours after the injection with L-arginine
( F5Figs. 5A, B). Pretreatment with AIHA did not inﬂuence NSG
FIGURE 3. (+)-S-2-amino-6-iodoacetamidohexanoic acid inhibits arginase activity of rat liver homogenate and puriﬁed bovine liver
arginase. The effect of 0 to 120 KM AIHA was tested on (A) rat liver homogenate or (B) puriﬁed bovine liver arginase. Sixty micromolars
of AIHA (equimolar to an in vivo dose of 15 mg/kg) signiﬁcantly inhibited arginase activity by about 25%.
FIGURE 2. Arginase activity in the liver, pancreas, lung, and
kidney of rats. Tissues were removed from control animals and
then homogenized. Arginase activity was measured by
exogenously added L-arginine using a colorimetric method, based
on the determination of released urea.9
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FIGURE 4. Effects of AIHA pretreatment on laboratory parameters of acute pancreatitis. A, PW/BW ratio and activities of (B) serum
and (C) pancreatic amylase and pancreatic (D) trypsin and (E) MPO. Rats were pretreated with 15 mg/kg AIHA (AIHA, +) or its vehicle
(AIHA,j) IP 1 hour before injection with physiological saline (Arg,j) or 3.5 g/kg L-arginineYHCl (Arg, +) IP. Rats were killed 24 hours after
the L-arginine or physiological saline injection. Means T SEM for 5 to 8 animals are shown. *Signiﬁcant difference (P G 0.05) versus the
control group.
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content, but signiﬁcantly reduced GSH-Px activity. Activities
of Cu/Zn and Mn SOD were unaltered by AIHA pretreatment
in the L-arginineYpancreatitis group (Figs. 5C, D).
Pancreatic HSP Expression
(+)-S-2-amino-6-iodoacetamidohexanoic acid and/or L-
arginine administration resulted in up-regulation of pancreatic
HSP27 and HSP72 synthesis versus the physiological salineY
treated control group (F6 Fig. 6). No signiﬁcant difference was
found at 24 hours between the AIHA-treated and untreated
L-arginineYinduced pancreatitis groups.
Histological Examination
The administration of 3.5 g/kg L-arginine caused severe
necrotizing pancreatitis (F7 Fig. 7;T1 Table 1). Injection of AIHA in
itself resulted in pancreatic hyperemia and mild inﬂammatory
cell inﬁltration. However, AIHA pretreatment signiﬁcantly
reduced pancreatic damage in L-arginineYinduced pancreatitis.
DISCUSSION
We have previously demonstrated that IP injection of
3.5 g/kg L-arginine results in much greater increases in serum
ornithine versus citrulline concentration.7 This ﬁnding suggested
a major role for arginase (rather than NOS) in the catabolism of
L-arginine. In the present study, we have shown that pretreatment
FIGURE 5. Effects of AIHA pretreatment on pancreatic markers of oxidative stress in L-arginineYinduced acute pancreatitis. Changes
in pancreatic (A) NSG content, (B) GSH-Px, and (C) Cu/Zn-SOD and (D) Mn-SOD activities are depicted. Rats were treated as indicated
in the legend of Figure 3. Means T SEM for 5 to 8 animals are shown. *Signiﬁcant difference (P G 0.05) versus the control group.
FIGURE 6. Effects of AIHA pretreatment on pancreatic HSP
synthesis in L-arginineYinduced pancreatitis. Representative
Western immunoblot analysis of protein lysates (40 Kg/lane)
from the pancreata of rats, showing the expression of HSP27 and
HSP72. Rats were treated as indicated in the legend of Figure 3.
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with the irreversible arginase inhibitor AIHA signiﬁcantly re-
duced pancreatic damage caused by the administration of 3.5 g/kg
L-arginine.
Arginase is a key enzyme of the hepatic urea cycle, so it
was not surprising that the highest enzyme activity was found in
the liver of rats. In accordance with values reported elsewhere,17
arginase activity was several-order magnitudes higher in the
liver compared with other tissues (pancreas, lung, and kidney).
Therefore, most likely, large doses of L-arginine are metabolized
mainly by the liver. In fact, serum L-arginine concentration was
signiﬁcantly reduced below the control value 24 hours after
injection.8
Two studies have investigated the changes in serum argi-
nase activity in patients with acute pancreatitis. Serum arginase
activity was unaltered in the early phases of acute pancreatitis.18
On the contrary, Scibior et al19 have found that serum arginase
activity was signiﬁcantly reduced by treatment of the disease.
(+)-S-2-amino-6-iodoacetamidohexanoic acid is an irre-
versible inhibitor of the ornithine decarboxylase and arginase
and has been reported to have antifertility and antitumor ef-
fects.20,21 The dosing of AIHAwas based on literature data.20,21
Sixty micromolars of AIHA (which corresponds to an in vivo
dose of 15 mg/kg) inhibited arginase activity by about 25%.
Although this rate of arginase inhibition is not great, even
F
ig
7
4/
C
FIGURE 7. Effects of AIHA pretreatment on the pancreatic morphological damage in L-arginineYinduced pancreatitis. The histological
pictures show hematoxylin-and-eosin staining images of the pancreas from control, AIHA (15 mg/kg IP), L-arginine (3.5 g/kg IP), or
AIHA + L-arginineYtreated rats. Original magniﬁcation 200. The point values for each of the scored parameters are shown in Table 1.
TABLE 1. Effects of AIHA Pretreatment on the Histological Parameters in Arginine-Induced Acute Pancreatitis
Control AIHA L-Arginine AIHA + L-Arginine
Vascular congestion 0.0 T 0.0 0.0 T 0.0 1.0 T 0.0* 1.0 T 0.0*
Leukocyte adherence 0.0 T 0.0 0.0 T 0.0 2.5 T 0.3* 1.5 T 0.3*†
Interstitial edema 0.0 T 0.0 0.0 T 0.0 2.3 T 0.5* 1.7 T 0.4*
Leukocyte infiltration 0.0 T 0.0 0.3 T 0.2 2.7 T 0.2* 1.7 T 0.2*†
Vacuolization 0.0 T 0.0 0.0 T 0.0 1.5 T 0.3* 0.5 T 0.4†
Necrosis 0.0 T 0.0 0.3 T 0.2 3.5 T 0.4* 1.5 T 0.4*†
Apoptosis 0.0 T 0.0 0.0 T 0.0 1.0 T 0.0* 1.0 T 0.0*
Regeneration 0.0 T 0.0 0.0 T 0.0 0.5 T 0.3 0.2 T 0.2
Total 0.0 T 0.0 0.5 T 0.4 15.0 T 1.5* 9.0 T 1.3*†
Rats were treated as indicated in the legend of Figure 3. Data are means T SEM for 5 to 8 animals.
*Signiﬁcant difference (P G 0.05) versus the control group.
†Signiﬁcant difference (P G 0.05) versus the L-arginineYtreated group.
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applying 120 KM AIHA in vitro did not result in signiﬁcantly
lower levels of arginase activity versus 60 KM (Fig. 3). Fur-
thermore, because arginase is a critical enzyme of the urea
cycle, most likely we have a limit to what we could decrease
enzyme activity without seeing any detrimental effects. Be-
cause AIHA also inhibits ornithine decarboxylase and ornithine
per se can induce acute pancreatitis, the action of AIHA in
modifying the acute pancreatitis response to arginine might be
due to the inhibition of the latter step, which is the formation
of precursor for polyamine synthesis.
Interestingly, administration of AIHA in itself caused a
stress response in the pancreas characterized by increased ex-
pression of HSP27 and HSP72. This may be due to the fact
that inhibition of arginase activity will interfere with the urea
cycle and increase levels of toxic ammonia. Preinduction of
HSPs has been shown to protect against L-arginineYinduced
acute pancreatitis,22 although in our studies we found only re-
ductions in proinﬂammatory cytokine synthesis.23 Nevertheless,
given these contrasting results, we cannot exclude the beneﬁ-
cial effect of these chaperones on disease progression, providing
their levels are increased before the initiation of arginine
pancreatitis.24
The administration of AIHA 1 hour before L-arginine in-
jection ameliorated the degree of pancreatic edema, but it did
not inﬂuence serum amylase activity in L-arginineYinduced pan-
creatitis. Serum amylase activity is not a good marker of dis-
ease severity in this pancreatitis model; it is usually only mildly
increased in the early phases of the disease. However, AIHA
pretreatment also signiﬁcantly reduced parameters of pancreatic
oxidative stress, trypsin and MPO activity, and histological
damage.
Taken together, our results suggest that AIHA pretreat-
ment reduces the severity of L-arginineYinduced acute pancre-
atitis most likely by inhibiting arginase activity. Conversion of
L-arginine to L-ornithine by arginase seems to be detrimental
in L-arginineYinduced acute pancreatitis. Further studies are
needed to determine how these basic amino acids produce pan-
creatic injury.
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